In this special podcast, Medtech Insight commercial/R&D editor Reed Miller talks to In Vivo executive editor Ashley Yeo about the annual MTI 100 list and the major trends facing the top medtech companies entering the third year of the pandemic.

Related articles:
https://medtech.pharmaintelligence.informa.com/datasets/company-rankings-2022
https://medtech.pharmaintelligence.informa.com/MT144758/MTI-100-Review-Medtechs-Drive-To-Keep-The-Status-Quo-In-A-Year-Like-No-Other
https://medtech.pharmaintelligence.informa.com/MT144772/MTI-2022-Outlook-The-PostCOVID-Mantra-For-Medtechs-Prioritize-Optimize-And-Modernize
https://medtech.pharmaintelligence.informa.com/MT144780/MTI-100-2022-Big-Cardio-Medtechs-Are-Moving-ESG-Agenda-To-Center-Stage